CalciMedica, Inc.CalciMedica, Inc.CalciMedica, Inc.

CalciMedica, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪56.22 M‬USD
−2.64USD
‪−34.36 M‬USD
‪5.08 M‬
Beta (1Y)
2.60

About CalciMedica, Inc.

CEO
Rachel Anne Leheny
Headquarters
La Jolla
Employees (FY)
14
Founded
2007
FIGI
BBG0088HHJ97
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CALC is 5.06 USD — it has decreased by 3.25% in the past 24 hours. Watch CalciMedica, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CalciMedica, Inc. stocks are traded under the ticker CALC.
CALC stock has fallen by 7.33% compared to the previous week, the month change is a 6.30% fall, over the last year CalciMedica, Inc. has showed a 4.35% decrease.
We've gathered analysts' opinions on CalciMedica, Inc. future price: according to them, CALC price has a max estimate of 22.00 USD and a min estimate of 8.00 USD. Watch CALC chart and read a more detailed CalciMedica, Inc. stock forecast: see what analysts think of CalciMedica, Inc. and suggest that you do with its stocks.
CALC reached its all-time high on Jun 14, 2023 with the price of 8.59 USD, and its all-time low was 1.00 USD and was reached on Apr 3, 2023. View more price dynamics on CALC chart.
See other stocks reaching their highest and lowest prices.
CALC stock is 3.76% volatile and has beta coefficient of 2.60. Track CalciMedica, Inc. stock price on the chart and check out the list of the most volatile stocks — is CalciMedica, Inc. there?
Today CalciMedica, Inc. has the market capitalization of ‪56.22 M‬, it has decreased by 10.19% over the last week.
Yes, you can track CalciMedica, Inc. financials in yearly and quarterly reports right on TradingView.
CalciMedica, Inc. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CALC earnings for the last quarter are 0.01 USD per share, whereas the estimation was −0.67 USD resulting in a 101.50% surprise. The estimated earnings for the next quarter are −0.50 USD per share. See more details about CalciMedica, Inc. earnings.
CalciMedica, Inc. revenue for the last quarter amounts to 0 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CALC net income for the last quarter is ‪130.00 K‬ USD, while the quarter before that showed ‪−4.15 M‬ USD of net income which accounts for 103.14% change. Track more CalciMedica, Inc. financial stats to get the full picture.
No, CALC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 13, 2024, the company has 14.00 employees. See our rating of the largest employees — is CalciMedica, Inc. on this list?
Like other stocks, CALC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CalciMedica, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CalciMedica, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CalciMedica, Inc. stock shows the neutral signal. See more of CalciMedica, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.